CYCLOPHOSPHAMIDE (INGENUS) J Code: J9073

Drug & Product Overview

HCPCS Descriptor Injection, cyclophosphamide (dr. reddy's), 5 mg

HCPCS Added Date April 1, 2024

Manufacturer Athenex

Route of Administration Intravenous

Generic Status Single-Source; Branded

Dosage Type Multi-Dose

Dosage Form Injection, Solution | Not Available

About CYCLOPHOSPHAMIDE (INGENUS)

Cyclophosphamide (ingenus) is a medication aligned to the HCPCS J Code: J9073 for billing, pricing, and reimbursement purposes in the United States. It is an Oncology drug administered via the intravenous route and manufactured by Athenex.

According to CMS Drug Use Information: Cyclophosphamide is used to treat various types of cancer. It is a chemotherapy drug that works by slowing or stopping cell growth. Cyclophosphamide also works by decreasing your immune system's response to various diseases. It is used to treat a certain type of kidney disease in children after other treatments have not worked.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. Showing 5 of 11 NDCs — log in for the full crosswalk.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
50742-0519-02	Cyclophosphamide (Ingenus)	Ingenus Pharmaceuticals LLC	100	500 MG / 2.5 ML
50742-0520-05	Cyclophosphamide (Ingenus)	Ingenus Pharmaceuticals LLC	200	cycloPHOSphamide Intra venous Solution … Login for More
68001-0564-22	Cyclophosphamide	BluePoint Laboratories	200	1000 MG / 5 ML
70860-0218-10	Cyclophosphamide	Athenex Pharmaceutical Division, LLC	400	cycloPHOSphamide Intra venous Solution … Login for More
75907-0189-35	Cyclophosphamide	Dr. Reddy's Labratories Inc.	400	2000 MG / 10 ML
•••••-••••-•• Log in to view	CYCLOPHOSPHAMIDE (INGENUS)
	CYCLOPHOSPHAMIDE (INGENUS)
	CYCLOPHOSPHAMIDE (INGENUS)

Login to view 6 more NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

CYCLOPHOSPHAMIDE (INGENUS) Pricing & Reimbursement

J9073 Private Payer Reimbursement

$0.86 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q3 2026

Cyclophosphamide 505(b)(2) Information:

HCPCS Code	Manufacturer	Active Ingredient	HCPCS Description
J9071	Eugia US	Cyclophosphamide	Injection, cyclophosphamide (auromedics), 5 mg
J9072	Avyxa Pharma	Cyclophosphamide	Injection, cyclophosphamide (frindovyx), 5 mg
J9073	Generic Code (Multiple Manufacturers)	Cyclophosphamide	Injection, cyclophosphamide (dr. reddy's), 5 mg
J9074	Sandoz	Cyclophosphamide	Injection, cyclophosphamide (sandoz), 5 mg
J9075	Generic Code (Multiple Manufacturers)	Cyclophosphamide	Injection, cyclophosphamide, not otherwise specified, 5 mg
J9076 Log in to view

Log in to view all 6 505(b)(2) codes

CYCLOPHOSPHAMIDE (INGENUS) CPT Administration Codes

CPT Code	Description
96413	Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415	Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)

Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

CYCLOPHOSPHAMIDE (INGENUS) Medically Unlikely Edits (MUE)

The most billing units of J9073 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 5 mg.

Practitioner Office & Hospital Outpatient

1,500 units / day

= 7,500 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

CYCLOPHOSPHAMIDE (INGENUS) Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Malignant Diseases (malignant lymphomas, multiple myeloma, leukemias, mycosis fungoides, neuroblastoma, adenocarcinoma of the ovary, retinoblastoma, carcinoma of the breast) Malignant lymphomas, multiple myeloma, leukemias, mycosis fungoides, neuroblastoma, adenocarcinoma of the ovary, retinoblastoma, carcinoma of the breast

Frequently Asked Questions

Is a Cyclophosphamide (Ingenus) billing and coding guide available?

We have not yet identified a manufacturer source of billing and coding information for Cyclophosphamide (Ingenus)

Is Cyclophosphamide (Ingenus) patient assistance information available?

Our team did not identify a source for Cyclophosphamide (Ingenus) patient assistance information. Please reach out to our team if you feel that this is a mistake.

Where can I find Cyclophosphamide (Ingenus) prescribing information?

Our team is still working to identify a source of prescribing information for CYCLOPHOSPHAMIDE (INGENUS)

Where can I find Cyclophosphamide (Ingenus) side effect information?

Information regarding CYCLOPHOSPHAMIDE (INGENUS)'s potential side effects can be found at MedlinePlus

Does billing CYCLOPHOSPHAMIDE (INGENUS) require JZ/JW wastage modifiers?

CMS does not include CYCLOPHOSPHAMIDE (INGENUS) (J9073) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J9073. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.